Fig. 6
From: N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
Survival curves for IgD MM using the Kaplan-Meier method and log-rank test. a Progression free survival (PFS) curves for patients with above median levels of NA2FB (red line, 10.9Â months) and patients with below median levels of NA2FB (blue line, 27.0Â months); (b) Overall survival (OS) curves for patients with above median levels of NA2FB (red line, 30.7Â months) and patients with below median levels of NA2FB (blue line, 41.6Â months)